Kewaunee Scientific (KEQU)
(Delayed Data from NSDQ)
$34.90 USD
-1.05 (-2.92%)
Updated Apr 26, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Kewaunee Scientific Corporation falls in the month of April .
All items in Millions except EPS data.
4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 | |
---|---|---|---|---|---|
Sales | 219 | 169 | 147 | 148 | 147 |
Cost Of Goods | 184 | 145 | 123 | 124 | 121 |
Gross Profit | 36 | 24 | 24 | 23 | 25 |
Selling & Adminstrative & Depr. & Amort Expenses | 30 | 27 | 25 | 26 | 23 |
Income After Depreciation & Amortization | 5 | -3 | -1 | -2 | 2 |
Non-Operating Income | 1 | 1 | -1 | 0 | 0 |
Interest Expense | 2 | 1 | 0 | 0 | 0 |
Pretax Income | 5 | -2 | -3 | -3 | 2 |
Income Taxes | 3 | 4 | 1 | 2 | 0 |
Minority Interest | 1 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1 | -6 | -4 | -5 | 2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | -6 | -4 | -5 | 2 |
Depreciation Footnote | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 8 | 0 | 1 | 0 | 5 |
Depreciation & Amortization (Cash Flow) | 3 | 3 | 3 | 3 | 3 |
Income After Depreciation & Amortization | 5 | -3 | -1 | -2 | 2 |
Earnings Per Share Data | 4/30/23 | 4/30/22 | 4/30/21 | 4/30/20 | 4/30/19 |
---|---|---|---|---|---|
Average Shares | 2.90 | 2.79 | 2.76 | 2.75 | 2.79 |
Diluted EPS Before Non-Recurring Items | 0.25 | -2.20 | -1.33 | -1.70 | 0.86 |
Diluted Net EPS (GAAP) | 0.25 | -2.20 | -1.33 | -1.70 | 0.55 |
Fiscal Year end for Kewaunee Scientific Corporation falls in the month of April .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 46.78 | 50.44 | 49.84 | 53.99 | 60.82 |
Cost Of Goods | 34.75 | 36.97 | 37.93 | 43.63 | 50.49 |
Gross Profit | 12.03 | 13.47 | 11.91 | 10.36 | 10.33 |
SG&A, R&D, and Dept/Amort Expenses | 8.22 | 8.36 | 8.11 | 7.66 | 8.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3.81 | 5.11 | 3.80 | 2.70 | 2.30 |
Non-Operating Income | 0.12 | 0.11 | 0.03 | 0.17 | 0.19 |
Interest Expense | 0.41 | 0.37 | 0.43 | 0.54 | 0.44 |
Pretax Income | 3.52 | 4.85 | 3.41 | 2.32 | 2.06 |
Income Taxes | 0.98 | 2.02 | 0.90 | 1.23 | 0.96 |
Minority Interest | 0.01 | 0.10 | 0.04 | 0.09 | 0.38 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 2.53 | 2.83 | 2.52 | 1.09 | 1.10 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 2.52 | 2.73 | 2.47 | 1.01 | 0.72 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 2.97 | 2.93 | 2.89 | 2.93 | 2.91 |
Diluted EPS Before Non-Recurring Items | 0.85 | 0.93 | 0.86 | 0.34 | 0.25 |
Diluted Net EPS (GAAP) | 0.85 | 0.93 | 0.86 | 0.36 | 0.25 |